Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385632 · ClinicalTrials.gov registry record
Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,224
- Enrollment target
NCT00385632: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00385632 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,224 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00385632 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,224 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
Interventions
- DRUG Antiretroviral Regimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,224 participants |
| Start Date | 2002-01 |
| Est. Completion | 2008-11 |
What the finished NCT00385632 record still lists
NCT00385632 is an observational study that tracks outcomes without assigning an intervention. Its 1,224 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Antiretroviral Regimens is the first listed.
NCT00385632 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00385632 about?
NCT00385632 is a clinical study titled "Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants". The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.
What is the current status of trial NCT00385632?
This trial is currently completed. The enrollment target is 1,224 participants. The study started on 2002-01. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00385632?
The interventions under investigation include: Antiretroviral Regimens (DRUG).
Who is sponsoring clinical trial NCT00385632?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia